Teclison
Start-ups
Information
Clinical stage biotech focusing on immuno-oncology. First asset in phase 2 with robust efficacy in all solid tumors.
Start-up
Yes
Country
United States
Join the event!
See all the content and easy-to-use features by logging in or registering!